Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Kidney International
|
January 20, 2024
The authors reply
Nicolas Benichou, Mouad Abouqateb, Alexandre Karras, et al.
American Journal of Preventive Cardiology
|
January 14, 2025
Vascular ageing manifestations and hypertension in the community
Guillermo A Alanis, Pierre Boutouyrie, Mouad Abouqateb, et al.
Leukemia
|
June 25, 2024
How risky is a second allogeneic stem cell transplantation?
Olaf Penack, Mouad Abouqateb, Christophe Peczynski, et al.
Blood Cancer Journal
|
March 15, 2024
PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantation
Olaf Penack, Mouad Abouqateb, Christophe Peczynski, et al.
Leukemia
|
March 28, 2024
ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?
Olaf Penack, Mouad Abouqateb, Christophe Peczynski, et al.
Leukemia
|
April 17, 2025
GVHD prophylaxis in matched related stem cell transplantation: Why post-transplant cyclophosphamide can be recommended a study by the EBMT transplant complications working party
Olaf Penack, Mouad Abouqateb, Christophe Peczynski, et al.
Bone Marrow Transplantation
|
August 19, 2025
Post-transplantation cyclophosphamide and antithymocyte globulin in 8/10 HLA-mismatched unrelated donor transplantation: the analysis on behalf of the transplant complications working party of the EBMT
Ivan Moiseev, Mouad Abouqateb, Christophe Peczynski, et al.
British Journal of Haematology
|
September 30, 2025
Outcomes after a second allogeneic haematopoietic stem cell transplant for relapsed paediatric acute myeloid leukaemia improved over time: A study from the EBMT Paediatric Diseases Working Party
Nimrod Buchbinder, Victor Michel, Arnaud Dalissier, et al.
Bone Marrow Transplantation
|
September 30, 2025
Single unrelated umbilical cord blood versus unmanipulated haploidentical HCT using PTCy in pediatric AML: a retrospective study on behalf of the EBMT PDWP and CTIWP
Benedetta Elena Di Majo, Mouad Abouqateb, Jacques-Emmanuel Galimard, et al.
Bone Marrow Transplantation
|
September 10, 2025
Improved GVHD-free relapse-free survival when rATG/ATLG is used in allo-HCT from matched sibling donors - an EBMT registry study by the Transplant Complications Working Party
Agnieszka Piekarska, Mouad Abouqateb, William Boreland, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Kidney International
|
January 20, 2024
The authors reply
Nicolas Benichou, Mouad Abouqateb, Alexandre Karras, et al.
American Journal of Preventive Cardiology
|
January 14, 2025
Vascular ageing manifestations and hypertension in the community
Guillermo A Alanis, Pierre Boutouyrie, Mouad Abouqateb, et al.
Leukemia
|
June 25, 2024
How risky is a second allogeneic stem cell transplantation?
Olaf Penack, Mouad Abouqateb, Christophe Peczynski, et al.
Blood Cancer Journal
|
March 15, 2024
PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantation
Olaf Penack, Mouad Abouqateb, Christophe Peczynski, et al.
Leukemia
|
March 28, 2024
ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?
Olaf Penack, Mouad Abouqateb, Christophe Peczynski, et al.
Leukemia
|
April 17, 2025
GVHD prophylaxis in matched related stem cell transplantation: Why post-transplant cyclophosphamide can be recommended a study by the EBMT transplant complications working party
Olaf Penack, Mouad Abouqateb, Christophe Peczynski, et al.
Bone Marrow Transplantation
|
August 19, 2025
Post-transplantation cyclophosphamide and antithymocyte globulin in 8/10 HLA-mismatched unrelated donor transplantation: the analysis on behalf of the transplant complications working party of the EBMT
Ivan Moiseev, Mouad Abouqateb, Christophe Peczynski, et al.
British Journal of Haematology
|
September 30, 2025
Outcomes after a second allogeneic haematopoietic stem cell transplant for relapsed paediatric acute myeloid leukaemia improved over time: A study from the EBMT Paediatric Diseases Working Party
Nimrod Buchbinder, Victor Michel, Arnaud Dalissier, et al.
Bone Marrow Transplantation
|
September 30, 2025
Single unrelated umbilical cord blood versus unmanipulated haploidentical HCT using PTCy in pediatric AML: a retrospective study on behalf of the EBMT PDWP and CTIWP
Benedetta Elena Di Majo, Mouad Abouqateb, Jacques-Emmanuel Galimard, et al.
Bone Marrow Transplantation
|
September 10, 2025
Improved GVHD-free relapse-free survival when rATG/ATLG is used in allo-HCT from matched sibling donors - an EBMT registry study by the Transplant Complications Working Party
Agnieszka Piekarska, Mouad Abouqateb, William Boreland, et al.
Page
of 1